Longacre S L, Kocsis J J, Witmer C M, Lee E W, Sammett D, Snyder R
J Toxicol Environ Health. 1981 Feb;7(2):223-37. doi: 10.1080/15287398109529974.
Repeated dosing of mice with benzene led to a dose-related decrease in red cell production as measured by the incorporation of 59Fe into developing erythrocytes. Phenol, catechol, and hydroquinone were observed in the urine, largely conjugated with glucuronic acid and ethereal sulfate. During repeated dosing, toluene-soluble radioactivity derived from labeled benzene was found to accumulate in blood, liver fat, and, most significantly, bone marrow. Greater accumulation was observed when water-soluble metabolites of benzene were examined in these organs. Covalent binding of benzene metabolites was also observed in liver and marrow during repetitive treatment. Both covalently bound and soluble metabolites accumulated in bone marrow, liver, and kidney over a 24-h period after a single administration of benzene. The highest levels of covalent binding were seen in kidney and liver after 3 d of dosing at 880 mg/kg, two doses per day. Studies in vitro demonstrated the necessity for metabolic activation to produce covalent binding from benzene. These studies demonstrate that increasing benzene toxicity during repetitive treatment of mice is accompanied by increases in the levels of both water-soluble and covalently bound benzene metabolites.
对小鼠重复给予苯会导致红细胞生成量出现与剂量相关的减少,这是通过将59Fe掺入发育中的红细胞来测定的。在尿液中观察到了苯酚、儿茶酚和对苯二酚,它们大多与葡萄糖醛酸和硫酸酯结合。在重复给药期间,发现源自标记苯的甲苯可溶性放射性物质在血液、肝脏脂肪中积累,最显著的是在骨髓中积累。当在这些器官中检测苯的水溶性代谢物时,观察到了更大程度的积累。在重复治疗期间,在肝脏和骨髓中也观察到了苯代谢物的共价结合。在单次给予苯后24小时内,共价结合物和可溶性代谢物在骨髓、肝脏和肾脏中均有积累。在每天给药两次、剂量为880mg/kg的情况下给药3天后,在肾脏和肝脏中观察到了最高水平的共价结合。体外研究表明,代谢活化是由苯产生共价结合所必需的。这些研究表明,在对小鼠进行重复治疗期间,苯毒性的增加伴随着水溶性和共价结合苯代谢物水平的增加。